A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Recombinant Herpes Zoster Vaccine

NCT06801509 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

540

Enrollment

INDUSTRY

Sponsor class

Conditions

Herpes Zoster

Interventions

BIOLOGICAL: Recombinant Herpes Zoster Vaccine (SCTV04C) Low-Dose
BIOLOGICAL: Recombinant Herpes Zoster Vaccine (SCTV04C) High-Dose
BIOLOGICAL: Placebo control: Saline
BIOLOGICAL: Shingrix®
BIOLOGICAL: Ganwei®

Sponsor

Sinocelltech Ltd.